DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Autoimmune thyroid disease	R-HSA-1643685	map05320	finasteride	57363	drug-path
Olfactory transduction	R-HSA-9751605	map04740	memantine	4054	drug-path
SNARE interactions in vesicular transport	R-HSA-428625	map04130	memantine	4054	drug-path
RNA polymerase	R-HSA-73864	map03020	memantine	4054	drug-path
Melanogenesis	R-HSA-5662702	map04916	irinotecan	6100671	drug-path
Ubiquitin mediated proteolysis	R-HSA-983153	map04120	irinotecan	6100671	drug-path
Pathways in cancer	R-HSA-9824443	map05200	irinotecan	6100671	drug-path
Taste transduction	R-HSA-162582	map04742	irinotecan	6100671	drug-path
Wnt signaling pathway	R-HSA-195721	map04310	irinotecan	6100671	drug-path
Huntington's disease	R-HSA-1643685	0	irinotecan	6100671	drug-path
Olfactory transduction	R-HSA-9751605	map04740	irinotecan	6100671	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	irinotecan	6100671	drug-path
p53 signaling pathway	R-HSA-168638	map04115	irinotecan	6100671	drug-path
Vibrio cholerae infection	R-HSA-9609646	map05110	irinotecan	6100671	drug-path
Chemokine signaling pathway	R-HSA-168638	map04062	irinotecan	6100671	drug-path
Parkinson's disease	R-HSA-1643685	0	irinotecan	6100671	drug-path
Cardiac muscle contraction	R-HSA-397014	map04260	irinotecan	6100671	drug-path
Calcium signaling pathway	R-HSA-381753	map04020	irinotecan	6100671	drug-path
Type II diabetes mellitus	R-HSA-2127377	map04930	irinotecan	6100671	drug-path
Proteasome	R-HSA-68819	map03050	irinotecan	6100671	drug-path